Its stimulant nature makes it unsuitable for individuals with uncontrolled hypertension, heart disease, hyperthyroidism, or psychiatric conditions like anxiety disorders
While theyre fundamentally similar medications, they differ slightly in their mechanism of action: Wegovy (semaglutide) is a GLP-1 agonist Zepbound (tirzepatide) is a dual agonist: GLP-1 + a glucose-dependent insulinotropic polypeptide (GIP) Both semaglutide and tirzepatide affect the hypothalamus and the hedonic eating centers, the brains center of appetite and cravings
Indeed, plasma choline was positively associated with a number of cardiovascular risk factors, such as BMI, percentage body fat, waist circumference, and serum triglycerides, and inversely associated with HDL-cholesterol
Why Semaglutide Causes Acid Reflux GLP-1 receptor activation in the gut significantly delays gastric emptying, the rate at which the stomach releases its contents into the small intestine
There are already quadruple receptors in the pipeline
Tirzepatide, a dual GIP/GLP-1 receptor agonist, powers both Mounjaro (diabetes) and Zepbound (weight management)